🇺🇸 FDA
Patent

US 8937064

Pyrazolo[1,5-a]pyrimidines useful as JAK2 inhibitors

granted A61PA61P35/00A61P35/02

Quick answer

US patent 8937064 (Pyrazolo[1,5-a]pyrimidines useful as JAK2 inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61P, A61P35/00, A61P35/02, A61P35/04, A61P43/00